Our Vision
Accessible First-line Glaucoma Care for All.

In The Press

EIC Partners with BELKIN Vision

BELKIN Vision to Receive €17.5M Grant from EIC

“We couldn’t be happier to be selected to receive EIC funding. This validation from the EU will help us to continue to drive our technology forward, allowing us to bring to market a treatment for glaucoma which will significantly impact population health and the prevention of blindness worldwide. We are grateful for the EIC’s support and look forward to a successful partnership,” Daria Lemann Blumenthal, CEO of BELKIN Vision.

January 2023
Glaucoma Today

Dr. Nate Radcliffe shares his thoughts on how expanding access to and delivery of SLT poses a great challenge. DSLT can help change that.

Read
May 2022
EyeWire TV

Watch this EyeWire TV feature announcing BELKIN Vision's CE Mark

Watch
April 2022
The Ophthalmologist

Feature: From Too Few Drops to DSLT - An Interview With Prof Gerd Auffarth

Read More
March 2022
The Jewish Chronicle

Health Supplement Feature: Vision of the future for Glaucoma

Read More
March 2022
ASCRS EyeWorld Magazine

The State of SLT: Advancing the Technology and its Adoption

Read More
February 2022
The Optician UK

Interview: Professor Augusto Azuara-Blanco discusses glaucoma treatment in the blink of an eye

Read More
February 2022
CTech by Calcalist

Interview: The Israeli Startup Treating the Silent Thief of Sight

Read More
January 2022
CRST Europe

Remote Diagnosis and Treatment of Glaucoma: DSLT's application in telemedicine

Read More
December 2021
EIC - European Innovation Council

BELKIN Vision wins €17.5M from the EU Innovation Council

Read More
December 2021
i24News

Watch CEO Daria Lemann Blumenthal in this interview on i24News about our disruptive DSLT glaucoma treatment.

Watch
September 2021
Glaucoma Physician

Developing DSLT - Interview with Prof Michael Belkin

Read More
June 2021
The Ophthalmologist

Let There Be (Laser) Light - How Updated EGS Guidelines Impact Market Adoption of our Technology

Read More
March 2021
Israel 21C

The Glaucoma Treatment That Only Takes Seconds

Read More
November 2020
Theia - Spotlight on Women in Health Ventures

Listen to this podcast with CEO Daria Lemann Blumenthal about her journey as a woman in medtech.

Listen
October 2020
AsiaTechDaily

Read this candid interview with CEO Daria Lemann-Blumenthal

Read More
September 2020
The Jerusalem Post

Opinion piece on 'Glaucoma care in a matter of seconds'

Read More
August 2020
Kan Halayla on Reshet Bet radio

Listen (in Hebrew) as Yaakov Eichler interviews Dr. Modi Goldenfeld about regular glaucoma exams and BELKIN Vision’s technology.

Listen
July 2020
VC Beat - China

BELKIN Vision Completes $12.25 Series B Financing Round

Read More
July 2020
Calcalist

BELKIN Vision Announces $12.2M Raised in Series B Funding

Read More
July 2020
The Ophthalmologist

Pushing Boundaries with Advanced Technologies

Read More
July 2020
OIS Israel 2020

Company Showcase

Read More
May 2020
OIS

Emerging Glaucoma Devices See Beyond IOP

Read More
April 2020
Ophthalmology Times

BELKIN Vision COVID-19 update

Read More
March 2020
Healio: OIS@SECO Meeting News

New Technologies Change Glaucoma Treatment Paradigm

Read More
March 2020
Glaucoma Physician

Glaucoma 360 forum provides Vision for 2020

Read More
February 2020
Healio

Interview with CEO Daria Lemann-Blumenthall

Read More
February 2020
Ocular Surgery News

US Edition Lindstrom's Opinion

Read More
June 2019
Ophthalmology Times

Novel DSLT Taking aim at greater access to glaucoma care

Read More
June 2017
+MASS DEVICE

Glaucoma Laser Developer BELKIN Vision raises $5M

Read More

visual
DSLT in Focus

Understanding Energy Transmission

visual
DSLT in Focus

Angle Pigmentation

visual
DSLT in Focus

Repeatability

Get our latest news and updates!

Subscribe to receive BELKIN Vision's Newsletter with the latest news and clinical updates.

Skip to content